30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Stoke Therapeutics Inc (STOK)

Track

Over the last 90 days, Stoke Therapeutics Inc. has seen significant insider selling, with a net value of -$489,820.60. Executives have been the primary sellers, contributing to a negative net insider count. The majority of recent transactions were planned or proposed sales by key executives, including the Chief Medical Officer and General Counsel.
Stock chart
Ticker: STOK Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Allan Jonathan
GENERAL COUNSEL & CORP SEC
1 sale — total 100,000 USD
Planned sale 16 Jun 2026
Value US$4,921,659.79 | Price 33.70 | Shares 67,118
Proposed sale 16 Jun 2026
Value US$902,934.67 | Price 407.59 | Shares 30,522
Planned sale 1 Jun 2026
Value US$100,000.00 | Price 30.58 | Shares 1,000
Planned sale 1 May 2026
Value US$73,547.97 | Price 32.79 | Shares 2,243
Proposed sale 1 May 2026
Value US$132,123.36 | Price 32.72 | Shares 4,038
Planned sale 1 Apr 2026
Value US$60,029.08 | Price 32.66 | Shares 1,838
Planned sale 1 Apr 2026
Value US$60,029.08 | Price 32.66 | Shares 1,838
Proposed sale 1 Apr 2026
Value US$59,845.28 | Price 32.56 | Shares 1,838
Planned sale 20 Mar 2026
Value US$20,679.15 | Price 34.41 | Shares 601
Planned sale 20 Mar 2026
Value US$292,358.90 | Price 33.64 | Shares 8,692
Proposed sale 20 Mar 2026
Value US$308,434.67 | Price 33.19 | Shares 9,293
Planned sale 19 Mar 2026
Value US$43,815.39 | Price 29.99 | Shares 1,461
Proposed sale 19 Mar 2026
Value US$45,320.22 | Price 31.02 | Shares 1,461
Sale 18 Mar 2026
Value US$3,383.55 | Price 32.85 | Shares 103
Sale 18 Mar 2026
Value US$15,353.99 | Price 31.79 | Shares 483
Sale 18 Mar 2026
Value US$190,831.18 | Price 31.28 | Shares 6,100
Sale 18 Mar 2026
Value US$985.50 | Price 32.85 | Shares 30
Sale 18 Mar 2026
Value US$4,418.64 | Price 31.79 | Shares 139
Sale 18 Mar 2026
Value US$55,122.06 | Price 31.28 | Shares 1,762
Sale 18 Mar 2026
Value US$1,215.45 | Price 32.85 | Shares 37
Sale 18 Mar 2026
Value US$5,467.67 | Price 31.79 | Shares 172
Sale 18 Mar 2026
Value US$67,979.70 | Price 31.28 | Shares 2,173
Sale 18 Mar 2026
Value US$2,365.20 | Price 32.85 | Shares 72
Sale 18 Mar 2026
Value US$10,617.46 | Price 31.79 | Shares 334
Sale 18 Mar 2026
Value US$132,080.20 | Price 31.28 | Shares 4,222
Sale 17 Mar 2026
Value US$86,342.16 | Price 33.38 | Shares 2,587
Sale 17 Mar 2026
Value US$117,108.83 | Price 32.74 | Shares 3,577
Sale 17 Mar 2026
Value US$24,964.80 | Price 33.38 | Shares 748
Sale 17 Mar 2026
Value US$33,819.80 | Price 32.74 | Shares 1,033
Sale 17 Mar 2026
Value US$30,772.12 | Price 33.38 | Shares 922
Sale 17 Mar 2026
Value US$41,710.00 | Price 32.74 | Shares 1,274
Sale 17 Mar 2026
Value US$59,775.34 | Price 33.38 | Shares 1,791
Sale 17 Mar 2026
Value US$81,062.75 | Price 32.74 | Shares 2,476
Planned sale 13 Mar 2026
Value US$22,264.00 | Price 36.80 | Shares 605
Proposed sale 13 Mar 2026
Value US$22,070.40 | Price 36.48 | Shares 605
Planned sale 10 Mar 2026
Value US$174,214.37 | Price 40.00 | Shares 4,355
Planned sale 10 Mar 2026
Value US$1,320,963.79 | Price 39.74 | Shares 33,243
Proposed sale 10 Mar 2026
Value US$3,467,361.48 | Price 38.31 | Shares 90,508
Planned sale 2 Mar 2026
Value US$286,715.15 | Price 39.66 | Shares 7,229
Proposed sale 2 Mar 2026
Value US$1,473,585.52 | Price 36.41 | Shares 40,472
Planned sale 8 Dec 2025
Value US$44,061.56 | Price 33.10 | Shares 1,331
Planned sale 8 Dec 2025
Value US$269,070.48 | Price 32.52 | Shares 8,274
Planned sale 8 Dec 2025
Value US$120,253.03 | Price 31.44 | Shares 3,825
Planned sale 8 Dec 2025
Value US$87,337.08 | Price 32.61 | Shares 2,678
Planned sale 8 Dec 2025
Value US$41,074.28 | Price 31.60 | Shares 1,300
Proposed sale 8 Dec 2025
Value US$414,584.10 | Price 30.87 | Shares 13,430
Proposed sale 8 Dec 2025
Value US$122,800.86 | Price 30.87 | Shares 3,978
Proposed sale 5 Dec 2025
Value US$67,720.05 | Price 31.05 | Shares 2,181
Proposed sale 5 Dec 2025
Value US$241,600.05 | Price 31.05 | Shares 7,781
Proposed sale 5 Dec 2025
Value US$61,758.45 | Price 31.05 | Shares 1,989
Planned sale 5 Dec 2025
Value US$15,923.00 | Price 31.85 | Shares 500
Planned sale 5 Dec 2025
Value US$52,357.77 | Price 31.15 | Shares 1,681
Sale 5 Dec 2025
Value US$199,480.66 | Price 31.33 | Shares 6,367
Planned sale 5 Dec 2025
Value US$62,345.80 | Price 31.35 | Shares 1,989
Sale 5 Dec 2025
Value US$52,415.76 | Price 31.33 | Shares 1,673
Planned sale 5 Dec 2025
Value US$74,444.74 | Price 31.76 | Shares 2,344
Planned sale 5 Dec 2025
Value US$168,997.18 | Price 31.08 | Shares 5,437
Sale 5 Dec 2025
Value US$31,455.72 | Price 31.33 | Shares 1,004
Sale 4 Dec 2025
Value US$38,550.49 | Price 31.32 | Shares 1,231
Sale 4 Dec 2025
Value US$160,647.00 | Price 30.76 | Shares 5,222
Sale 4 Dec 2025
Value US$10,115.20 | Price 31.32 | Shares 323
Sale 4 Dec 2025
Value US$42,238.29 | Price 30.76 | Shares 1,373
Sale 4 Dec 2025
Value US$6,075.38 | Price 31.32 | Shares 194
Sale 4 Dec 2025
Value US$25,349.12 | Price 30.76 | Shares 824
Sale 3 Dec 2025
Value US$43,001.69 | Price 30.85 | Shares 1,394
Sale 3 Dec 2025
Value US$27,243.52 | Price 30.34 | Shares 898
Sale 3 Dec 2025
Value US$37,788.43 | Price 30.85 | Shares 1,225
Sale 3 Dec 2025
Value US$23,936.68 | Price 30.34 | Shares 789
Sale 3 Dec 2025
Value US$20,081.85 | Price 30.85 | Shares 651
Sale 3 Dec 2025
Value US$12,711.62 | Price 30.34 | Shares 419
Sale 2 Dec 2025
Value US$26,163.17 | Price 30.14 | Shares 868
Sale 2 Dec 2025
Value US$41,859.79 | Price 29.56 | Shares 1,416
Sale 2 Dec 2025
Value US$22,968.13 | Price 30.14 | Shares 762
Sale 2 Dec 2025
Value US$36,775.13 | Price 29.56 | Shares 1,244
Sale 2 Dec 2025
Value US$12,207.47 | Price 30.14 | Shares 405
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-18 2026-06-16 PlS Planned sale
2.6
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
67,118 -30.0%
33.70
US$4,921,660 		67,118 -30.0% 33.70 US$4,921,660
2026-06-16 2026-06-16 PrS Proposed sale
2.6
JONATHAN D ALLAN

Officer

Officer
30,522
407.59
US$902,935 		30,522 407.59 US$902,935
2026-06-03 2026-06-01 PlS Planned sale
2.6
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
30,367 -0.8%
467.32
US$4,186,197 		30,367 -0.8% 467.32 US$4,186,197
2026-05-05 2026-05-01 PlS Planned sale
2.6
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
2,243 -5.8%
32.79
US$73,548 		2,243 -5.8% 32.79 US$73,548
2026-05-01 2026-05-01 PrS Proposed sale
2.6
BARUCH S. TICHO

Officer

Officer
4,038
32.72
US$132,123 		4,038 32.72 US$132,123
2026-04-03 2026-04-01 PlS Planned sale
2.6
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
1,838 -4.5%
32.66
US$60,029 		1,838 -4.5% 32.66 US$60,029
2026-04-03 2026-04-01 PlS Planned sale
2.6
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
1,838 -4.5%
32.66
US$60,029 		1,838 -4.5% 32.66 US$60,029
2026-04-01 2026-04-01 PrS Proposed sale
2.6
BARUCH S. TICHO

Officer

Officer
1,838
32.56
US$59,845 		1,838 32.56 US$59,845
2026-03-24 2026-03-20 PlS Planned sale
2.6
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
601 -3.0%
34.41
US$20,679 		601 -3.0% 34.41 US$20,679
2026-03-24 2026-03-20 PlS Planned sale
2.6
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
8,692 -30.1%
33.64
US$292,359 		8,692 -30.1% 33.64 US$292,359
2026-03-20 2026-03-20 PrS Proposed sale
2.6
JONATHAN ALLAN

Officer

Officer
9,293
33.19
US$308,435 		9,293 33.19 US$308,435
2026-03-19 2026-03-19 PlS Planned sale
2.6
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
1,461 -3.5%
29.99
US$43,815 		1,461 -3.5% 29.99 US$43,815
2026-03-19 2026-03-19 PrS Proposed sale
2.6
BARUCH S. TICHO

Officer

Officer
1,461
31.02
US$45,320 		1,461 31.02 US$45,320
2026-03-19 2026-03-18 S Sale
2.6
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
103 -0.3%
32.85
US$3,384 		103 -0.3% 32.85 US$3,384
2026-03-19 2026-03-18 S Sale
2.6
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
483 -1.2%
31.79
US$15,354 		483 -1.2% 31.79 US$15,354
2026-03-19 2026-03-18 S Sale
2.6
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
6,100 -12.8%
31.28
US$190,831 		6,100 -12.8% 31.28 US$190,831
2026-03-19 2026-03-18 S Sale
3.2
Hoitt Jason

Chief Patient Officer

Officer
30 -0.3%
32.85
US$986 		30 -0.3% 32.85 US$986
2026-03-19 2026-03-18 S Sale
3.2
Hoitt Jason

Chief Patient Officer

Officer
139 -1.3%
31.79
US$4,419 		139 -1.3% 31.79 US$4,419
2026-03-19 2026-03-18 S Sale
3.2
Hoitt Jason

Chief Patient Officer

Officer
1,762 -14.4%
31.28
US$55,122 		1,762 -14.4% 31.28 US$55,122
2026-03-19 2026-03-18 S Sale
Leggett Thomas

Chief Financial Officer

Officer
37 -0.4%
32.85
US$1,215 		37 -0.4% 32.85 US$1,215
2026-03-19 2026-03-18 S Sale
Leggett Thomas

Chief Financial Officer

Officer
172 -1.7%
31.79
US$5,468 		172 -1.7% 31.79 US$5,468
2026-03-19 2026-03-18 S Sale
Leggett Thomas

Chief Financial Officer

Officer
2,173 -17.3%
31.28
US$67,980 		2,173 -17.3% 31.28 US$67,980
2026-03-19 2026-03-18 S Sale
2.6
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
72 -0.2%
32.85
US$2,365 		72 -0.2% 32.85 US$2,365
2026-03-19 2026-03-18 S Sale
2.6
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
334 -1.1%
31.79
US$10,617 		334 -1.1% 31.79 US$10,617
2026-03-19 2026-03-18 S Sale
2.6
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
4,222 -12.6%
31.28
US$132,080 		4,222 -12.6% 31.28 US$132,080
2026-03-19 2026-03-17 S Sale
2.6
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
2,587 -5.2%
33.38
US$86,342 		2,587 -5.2% 33.38 US$86,342
2026-03-19 2026-03-17 S Sale
2.6
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
3,577 -6.7%
32.74
US$117,109 		3,577 -6.7% 32.74 US$117,109
2026-03-19 2026-03-17 S Sale
3.2
Hoitt Jason

Chief Patient Officer

Officer
748 -5.8%
33.38
US$24,965 		748 -5.8% 33.38 US$24,965
2026-03-19 2026-03-17 S Sale
3.2
Hoitt Jason

Chief Patient Officer

Officer
1,033 -7.4%
32.74
US$33,820 		1,033 -7.4% 32.74 US$33,820
2026-03-19 2026-03-17 S Sale
Leggett Thomas

Chief Financial Officer

Officer
922 -6.8%
33.38
US$30,772 		922 -6.8% 33.38 US$30,772
2026-03-19 2026-03-17 S Sale
Leggett Thomas

Chief Financial Officer

Officer
1,274 -8.6%
32.74
US$41,710 		1,274 -8.6% 32.74 US$41,710
2026-03-19 2026-03-17 S Sale
2.6
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
1,791 -5.1%
33.38
US$59,775 		1,791 -5.1% 33.38 US$59,775
2026-03-19 2026-03-17 S Sale
2.6
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
2,476 -6.6%
32.74
US$81,063 		2,476 -6.6% 32.74 US$81,063
2026-03-17 2026-03-13 PlS Planned sale
1.2
LEVIN ARTHUR A
Non-Executive Director
605 -12.5%
36.80
US$22,264 		605 -12.5% 36.80 US$22,264
2026-03-13 2026-03-13 PrS Proposed sale
1.2
ARTHUR A LEVIN

Director

Non-Executive Director
605
36.48
US$22,070 		605 36.48 US$22,070
2026-03-12 2026-03-10 PlS Planned sale
TZIANABOS ARTHUR

Interim Executive Chair

Executive Director
4,355 -12.2%
40.00
US$174,214 		4,355 -12.2% 40.00 US$174,214
2026-03-12 2026-03-10 PlS Planned sale
Krainer Adrian R.
Non-Executive Director
33,243 -10.5%
39.74
US$1,320,964 		33,243 -10.5% 39.74 US$1,320,964
2026-03-10 2026-03-10 PrS Proposed sale
ARTHUR TZIANABOS

Director

Non-Executive Director
90,508
38.31
US$3,467,361 		90,508 38.31 US$3,467,361
2026-03-04 2026-03-02 PlS Planned sale
Krainer Adrian R.
Non-Executive Director
7,229 -2.2%
39.66
US$286,715 		7,229 -2.2% 39.66 US$286,715
2026-03-02 2026-03-02 PrS Proposed sale
Adrian Krainer

Director

Non-Executive Director
40,472
36.41
US$1,473,586 		40,472 36.41 US$1,473,586
2025-12-10 2025-12-08 PlS Planned sale
2.8
Kaye Edward M. MD
Non-Executive Director
1,331 -2.6%
33.10
US$44,062 		1,331 -2.6% 33.10 US$44,062
2025-12-10 2025-12-08 PlS Planned sale
2.8
Kaye Edward M. MD
Non-Executive Director
8,274 -14.1%
32.52
US$269,070 		8,274 -14.1% 32.52 US$269,070
2025-12-10 2025-12-08 PlS Planned sale
2.8
Kaye Edward M. MD
Non-Executive Director
3,825 -6.1%
31.44
US$120,253 		3,825 -6.1% 31.44 US$120,253
2025-12-10 2025-12-08 PlS Planned sale
2.6
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
2,678 -18.5%
32.61
US$87,337 		2,678 -18.5% 32.61 US$87,337
2025-12-10 2025-12-08 PlS Planned sale
2.6
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
1,300 -8.2%
31.60
US$41,074 		1,300 -8.2% 31.60 US$41,074
2025-12-08 2025-12-08 PrS Proposed sale
2.8
EDWARD M KAYE

Director

Non-Executive Director
13,430
30.87
US$414,584 		13,430 30.87 US$414,584
2025-12-08 2025-12-08 PrS Proposed sale
2.6
JONATHAN ALLAN

Officer

Officer
3,978
30.87
US$122,801 		3,978 30.87 US$122,801
2025-12-05 2025-12-05 PrS Proposed sale
2.8
EDWARD M KAYE

Director

Non-Executive Director
2,181
31.05
US$67,720 		2,181 31.05 US$67,720
2025-12-05 2025-12-05 PrS Proposed sale
2.6
JONATHAN ALLAN

Officer

Officer
7,781
31.05
US$241,600 		7,781 31.05 US$241,600
2025-12-05 2025-12-05 PrS Proposed sale
2.6
BARUCH TICHO

Officer

Officer
1,989
31.05
US$61,758 		1,989 31.05 US$61,758
2025-12-05 2025-12-05 PlS Planned sale
2.8
Kaye Edward M. MD
Non-Executive Director
500 -0.8%
31.85
US$15,923 		500 -0.8% 31.85 US$15,923
2025-12-05 2025-12-05 PlS Planned sale
2.8
Kaye Edward M. MD
Non-Executive Director
1,681 -2.6%
31.15
US$52,358 		1,681 -2.6% 31.15 US$52,358
2025-12-05 2025-12-05 S Sale
2.8
Kaye Edward M. MD
Non-Executive Director
6,367 -9.0%
31.33
US$199,481 		6,367 -9.0% 31.33 US$199,481
2025-12-05 2025-12-05 PlS Planned sale
2.6
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
1,989 -9.1%
31.35
US$62,346 		1,989 -9.1% 31.35 US$62,346
2025-12-05 2025-12-05 S Sale
2.6
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
1,673 -7.1%
31.33
US$52,416 		1,673 -7.1% 31.33 US$52,416
2025-12-05 2025-12-05 PlS Planned sale
2.6
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
2,344 -12.9%
31.76
US$74,445 		2,344 -12.9% 31.76 US$74,445
2025-12-05 2025-12-05 PlS Planned sale
2.6
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
5,437 -23.0%
31.08
US$168,997 		5,437 -23.0% 31.08 US$168,997
2025-12-05 2025-12-05 S Sale
2.6
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
1,004 -4.1%
31.33
US$31,456 		1,004 -4.1% 31.33 US$31,456
2025-12-05 2025-12-04 S Sale
2.8
Kaye Edward M. MD
Non-Executive Director
1,231 -1.7%
31.32
US$38,550 		1,231 -1.7% 31.32 US$38,550
2025-12-05 2025-12-04 S Sale
2.8
Kaye Edward M. MD
Non-Executive Director
5,222 -6.7%
30.76
US$160,647 		5,222 -6.7% 30.76 US$160,647
2025-12-05 2025-12-04 S Sale
2.6
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
323 -1.4%
31.32
US$10,115 		323 -1.4% 31.32 US$10,115
2025-12-05 2025-12-04 S Sale
2.6
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
1,373 -5.5%
30.76
US$42,238 		1,373 -5.5% 30.76 US$42,238
2025-12-05 2025-12-04 S Sale
2.6
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
194 -0.8%
31.32
US$6,075 		194 -0.8% 31.32 US$6,075
2025-12-05 2025-12-04 S Sale
2.6
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
824 -3.2%
30.76
US$25,349 		824 -3.2% 30.76 US$25,349
2025-12-03 2025-12-03 S Sale
2.6
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
1,394 -6.6%
30.85
US$43,002 		1,394 -6.6% 30.85 US$43,002
2025-12-03 2025-12-03 S Sale
2.6
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
898 -4.1%
30.34
US$27,244 		898 -4.1% 30.34 US$27,244
2025-12-03 2025-12-03 S Sale
2.6
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
1,225 -7.5%
30.85
US$37,788 		1,225 -7.5% 30.85 US$37,788
2025-12-03 2025-12-03 S Sale
2.6
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
789 -4.6%
30.34
US$23,937 		789 -4.6% 30.34 US$23,937
2025-12-03 2025-12-03 S Sale
2.8
Kaye Edward M. MD
Non-Executive Director
651 -1.3%
30.85
US$20,082 		651 -1.3% 30.85 US$20,082
2025-12-03 2025-12-03 S Sale
2.8
Kaye Edward M. MD
Non-Executive Director
419 -0.8%
30.34
US$12,712 		419 -0.8% 30.34 US$12,712
2025-12-03 2025-12-02 S Sale
2.6
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
868 -3.8%
30.14
US$26,163 		868 -3.8% 30.14 US$26,163
2025-12-03 2025-12-02 S Sale
2.6
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
1,416 -5.9%
29.56
US$41,860 		1,416 -5.9% 29.56 US$41,860
2025-12-03 2025-12-02 S Sale
2.6
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
762 -4.2%
30.14
US$22,968 		762 -4.2% 30.14 US$22,968
2025-12-03 2025-12-02 S Sale
2.6
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
1,244 -6.5%
29.56
US$36,775 		1,244 -6.5% 29.56 US$36,775
2025-12-03 2025-12-02 S Sale
2.8
Kaye Edward M. MD
Non-Executive Director
405 -0.8%
30.14
US$12,207 		405 -0.8% 30.14 US$12,207
Explore more

More insider trading research around Stoke Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America